CN1679650A - Preparation of Fuyankang for gynecopathy - Google Patents
Preparation of Fuyankang for gynecopathy Download PDFInfo
- Publication number
- CN1679650A CN1679650A CN 200410023787 CN200410023787A CN1679650A CN 1679650 A CN1679650 A CN 1679650A CN 200410023787 CN200410023787 CN 200410023787 CN 200410023787 A CN200410023787 A CN 200410023787A CN 1679650 A CN1679650 A CN 1679650A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- radix
- vinegar
- processed
- fuyankang
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
A Chinese medicine 'Fuyankang' in the form of effervescent tablet for treating gynopathic inflammation is prepared from 13 Chinese-medicinal materials including red peony root, China root, Chinese angelica root, red sage root etc through respectively extracting volatile oil liquid extract and decocting, filtering, concentrating, drying, pulverizing, adding effervescent agent, granulating and tabletting.
Description
Invention field
The present invention relates to a kind of 'Fuyankang ', belong to field of traditional Chinese.
Background technology
The gynecologic chronic inflammatory diseases is to be caused by pathogenic microorganism such as antibacterial, fungus, chlamydia, mycoplasmas mostly, comprises pelvic inflammatory disease, vaginitis, adnexitis etc., is one of common disease that influences WomanHealth.Show that according to interrelated data the prevalence of China adult female gynecologic chronic inflammatory diseases is 80%.At present the treatment of this disease still there is not specific short.Modern medicine relies on antibiotic therapy more, but widely applies antibiotic can cause many adverse consequencess for a long time, as liver, renal damage or chemical sproof generation.This disease of traditional Chinese medical herbal treatment has special advantages and better therapeutic effect.Present domestic FUYANKANG PIAN, capsule and the granule developed, bioavailability is lower.
Summary of the invention
The object of the invention provides a kind of 'Fuyankang ' that can treat female chronic inflammation fast, that bioavailability is high that absorbs.
Technical solution of the present invention is as follows:
'Fuyankang ', it is characterized in that comprising Radix Paeoniae Rubra, Rhizoma Smilacis Glabrae, rhizoma sparganic (processed with vinegar), Fructus Toosendan (stir-fry), Rhizoma Curcumae (processed with vinegar), Rhizoma Corydalis (processed with vinegar), Semen Euryales (stir-fry), Radix Angelicae Sinensis, Radix Sophorae Flavescentis, Rhizoma Cyperi (processed with vinegar), Cortex Phellodendri, Radix Salviae Miltiorrhizae, Rhizoma Dioscoreae Chinese medicine ingredients, the percentage by weight of each composition is Radix Paeoniae Rubra 5～7, Rhizoma Smilacis Glabrae 9～11, rhizoma sparganic 5～7, Fructus Toosendan 5～7, Rhizoma Curcumae 5～7, Rhizoma Corydalis 5～7, Semen Euryales 9～11, Radix Angelicae Sinensis 9～11, Radix Sophorae Flavescentis 5～7, Rhizoma Cyperi 3～5, Cortex Phellodendri 5～7, Radix Salviae Miltiorrhizae 9～11, Rhizoma Dioscoreae 11～13.
Technical solution of the present invention also comprises:
The preparation method of 'Fuyankang ' is characterized in that getting Rhizoma Curcumae (processed with vinegar) 60g, is ground into coarse powder, and steam distillation is collected volatile oil, volatile oil beta-cyclodextrin inclusion compound.Other gets Radix Paeoniae Rubra 60g, Rhizoma Smilacis Glabrae 100g, rhizoma sparganic (processed with vinegar) 60g, Fructus Toosendan (stir-fry) 60g, Rhizoma Corydalis (processed with vinegar) 60g, Semen Euryales (stir-fry) 100g, Radix Angelicae Sinensis 100g, Radix Sophorae Flavescentis 60g, Rhizoma Cyperi (processed with vinegar) 40, Cortex Phellodendri 60g, Radix Salviae Miltiorrhizae 100g adds 6～8 times of water gagings respectively and decocts 1～3 time, medicinal residues add Rhizoma Dioscoreae 120g and above-mentioned Rhizoma Curcumae medicinal residues mix, adding 6～8 times of water gagings decocts 2 times, the 1st time 1～2 hour, the 2nd time 1～2 hour, merge all decocting liquids, filter, filtrate is concentrated into relative density 1.08～1.12 (60 ℃), adds the ethanol precipitate with ethanol of equivalent, leaves standstill, filter, reclaim ethanol, drying was pulverized 80 mesh sieves, fine powder is divided into 2 parts, add an amount of soluble starch as excipient, and add an amount of citric acid and sodium bicarbonate composition respectively, granulate respectively as effervescent, oven dry, mixing, compacting is in blocks, promptly.
The present invention is the oral Chinese medicine preparation of treatment female chronic inflammation, and the medicine compatibility with sweet using warming therapy product and bitter cold in the side is used the effect of playing blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing altogether.Pharmacological experiments shows that the effective ingredient of Cortex Phellodendri is a berberine, and is inhibited to various bacteria, fungus and other pathogenic microorganisms.Cyperol extract in the Rhizoma Cyperi has antiinflammatory action.Radix Paeoniae Rubra also has the effect of antiinflammatory and resisting pathogenic microbes.The effect that in addition blood system is had antiplatelet aggregation.
Advantage of the present invention is: dosage form of the present invention is an effervescent tablet, meets water and can produce carbon dioxide and make the quick disintegrate of tablet, has the advantage that drug effect is rapid, absorption is fast, bioavailability is high.
The specific embodiment
Effervescent tablet is got Rhizoma Curcumae (processed with vinegar) 60g, is ground into coarse powder, and steam distillation is collected volatile oil, volatile oil beta-cyclodextrin inclusion compound.Other gets Radix Paeoniae Rubra 60g, Rhizoma Smilacis Glabrae 100g, rhizoma sparganic (processed with vinegar) 60g, Fructus Toosendan (stir-fry) 60g, Rhizoma Corydalis (processed with vinegar) 60g, Semen Euryales (stir-fry) 100g, Radix Angelicae Sinensis 100g, Radix Sophorae Flavescentis 60g, Rhizoma Cyperi (processed with vinegar) 40, Cortex Phellodendri 60g, Radix Salviae Miltiorrhizae 100g adds 8 times of water gagings respectively and decocts 1 time, medicinal residues add Rhizoma Dioscoreae 120g and above-mentioned Rhizoma Curcumae medicinal residues mix, adding 6 times of water gagings decocts 2 times, the 1st time 1 hour, the 2nd time 1 hour, merge all decocting liquids, filter, filtrate is concentrated into relative density 1.10 (60 ℃), adds the ethanol precipitate with ethanol of equivalent, leaves standstill, filter, reclaim ethanol, drying was pulverized 80 mesh sieves, fine powder is divided into 2 parts, add an amount of soluble starch as excipient, and add an amount of citric acid and sodium bicarbonate composition respectively, granulate respectively as effervescent, oven dry, mixing, compacting is in blocks, promptly.
Claims (3)
1, a kind of 'Fuyankang ', it is characterized in that comprising Radix Paeoniae Rubra, Rhizoma Smilacis Glabrae, rhizoma sparganic (processed with vinegar), Fructus Toosendan (stir-fry), Rhizoma Curcumae (processed with vinegar), Rhizoma Corydalis (processed with vinegar), Semen Euryales (stir-fry), Radix Angelicae Sinensis, Radix Sophorae Flavescentis, Rhizoma Cyperi (processed with vinegar), Cortex Phellodendri, Radix Salviae Miltiorrhizae, Rhizoma Dioscoreae Chinese medicine ingredients, the percentage by weight of each composition is Radix Paeoniae Rubra 5～7, Rhizoma Smilacis Glabrae 9～11, rhizoma sparganic 5～7, Fructus Toosendan 5～7, Rhizoma Curcumae 5～7, Rhizoma Corydalis 5～7, Semen Euryales 9～11, Radix Angelicae Sinensis 9～11, Radix Sophorae Flavescentis 5～7, Rhizoma Cyperi 3～5, Cortex Phellodendri 5～7, Radix Salviae Miltiorrhizae 9～11, Rhizoma Dioscoreae 11～13.
2, according to the described a kind of 'Fuyankang ' of claim 1, it is characterized in that can be made into effervescent tablet.
3, according to the described a kind of 'Fuyankang ' of claim 1, it is characterized in that preparation technology takes by weighing the Rhizoma Curcumae medical material by recipe quantity, collect volatile oil and extracting solution, the volatile oil beta-cyclodextrin inclusion compound.All the other 12 flavor medical materials add 6～8 times of water gagings and decoct, and collecting decoction filters, filtrate is concentrated into relative density 1.08～1.12, adds the ethanol precipitate with ethanol of equivalent, leaves standstill, filter, reclaim ethanol, drying, be ground into fine powder, fine powder is divided into 2 parts, adds an amount of excipient, and add an amount of organic acid and alkalescence composition respectively as effervescent, granulate oven dry respectively, mixing, compacting is in blocks, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410023787 CN1679650A (en) | 2004-04-05 | 2004-04-05 | Preparation of Fuyankang for gynecopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410023787 CN1679650A (en) | 2004-04-05 | 2004-04-05 | Preparation of Fuyankang for gynecopathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1679650A true CN1679650A (en) | 2005-10-12 |
Family
ID=35066656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410023787 Pending CN1679650A (en) | 2004-04-05 | 2004-04-05 | Preparation of Fuyankang for gynecopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1679650A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101461916B (en) * | 2008-08-11 | 2011-03-16 | 王雷 | External-use Chinese medicinal composition for treating gynecopathy and method for formulating the same |
| CN101176779B (en) * | 2006-11-07 | 2011-07-13 | 广东德鑫制药有限公司 | Preparation method of enema for curing gynecology inflammation |
| CN102652819A (en) * | 2012-03-06 | 2012-09-05 | 深圳市国源药业有限公司 | Fuyankang dispersible tablet and preparation method thereof |
| CN105521439A (en) * | 2016-01-14 | 2016-04-27 | 江西京通美联药业有限公司 | Preparation method of pharmaceutical preparation for promoting blood circulation and removing stasis, diminishing inflammation and relieving pain |
-
2004
- 2004-04-05 CN CN 200410023787 patent/CN1679650A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101176779B (en) * | 2006-11-07 | 2011-07-13 | 广东德鑫制药有限公司 | Preparation method of enema for curing gynecology inflammation |
| CN101461916B (en) * | 2008-08-11 | 2011-03-16 | 王雷 | External-use Chinese medicinal composition for treating gynecopathy and method for formulating the same |
| CN102652819A (en) * | 2012-03-06 | 2012-09-05 | 深圳市国源药业有限公司 | Fuyankang dispersible tablet and preparation method thereof |
| CN105521439A (en) * | 2016-01-14 | 2016-04-27 | 江西京通美联药业有限公司 | Preparation method of pharmaceutical preparation for promoting blood circulation and removing stasis, diminishing inflammation and relieving pain |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1899535A (en) | Method for preparing dermopathic blood toxic capsule | |
| CN101518580A (en) | Pharmaceutical composition for clearing heat and releasing toxin as well as preparation method and application thereof | |
| CN101773655A (en) | Anti-AIDS nanometer Chinese medicine and production method thereof | |
| CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
| CN1689613A (en) | Prescription and preparation of product for preventing and treating wind-heat type cold and virus infected cold | |
| CN108721431B (en) | Traditional Chinese medicine composition for removing heavy metals and application thereof | |
| CN1679650A (en) | Preparation of Fuyankang for gynecopathy | |
| CN1660392A (en) | 'Changyuan' capsule and preparing techniue | |
| CN1323708C (en) | Medicine for treating premenstrual syndrome invansion of hyperactive liver-qi and its prepn. method | |
| CN104906366A (en) | Pharmaceutical preparation for treating delayed menorrhea | |
| CN104606519A (en) | Novel preparation method of antelope cold preparation | |
| CN1985944A (en) | Chinese medicine composition for treating cutaneous pruritus, rubella and other diseases | |
| CN1823925A (en) | New preparation for treating constrained liver qi | |
| CN1180821C (en) | Medicine for treating cerebral thrombus and its prepn | |
| CN100522238C (en) | Pain-relieving and abdominal mass-eliminatnig bolus and its preparation | |
| CN106728081B (en) | Preparation method of capsule for clearing away turbid and tonifying kidney | |
| CN102755519B (en) | Kudzuvine root-kudzuvine flower anti-canker sore particle and preparation method thereof | |
| CN101716226A (en) | Health-care medicine for preventing and treating influenza and preparation method thereof | |
| CN105343688A (en) | Medicine composition for treating myocardial infarction and application thereof | |
| CN104784418A (en) | Medicine for curing protrusion of lumbar intervertebral disc | |
| CN1857672A (en) | Cholelithiasis treating Danshitongli tablet and its preparing method | |
| CN101278982A (en) | Chinese medicine compound preparation for curing acute or chronic hepatitis B and method of preparing the same | |
| CN101129470A (en) | WulingGanfu patch and method of preparing the same | |
| CN100488495C (en) | A Chinese medicinal preparation for treating rheumatism, hyperosteogeny and osteoporosis and method for preparing same | |
| CN109125703A (en) | A kind of pharmaceutical composition and preparation method thereof for treating vaginitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |